The latest report by IMARC Group, titled “Endoluminal Suturing Devices Market Report by Application (Bariatric Surgery, Gastrointestinal Surgery, Gastroesophageal Surgery, and Others), End Use (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2023-2028“, The global endoluminal suturing devices market size reached US$ 64.2 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 128.7 Million by 2028, exhibiting a growth rate (CAGR) of 12.40% during 2023-2028.
Endoluminal suturing devices are advanced medical tools designed for minimally invasive surgery within the body’s hollow structures, particularly the gastrointestinal tract. They enable surgeons to perform suturing and stitching procedures from within these luminal spaces without the need for traditional open surgery. Endoluminal suturing is commonly used for treating conditions like obesity, gastroesophageal reflux disease (GERD), and gastrointestinal leaks. These devices typically consist of a flexible catheter or endoscope equipped with specialized instruments, including needles and suturing mechanisms, allowing for precise and controlled stitching. Surgeons manipulate these instruments to suture or staple tissues, creating secure closures or alterations to address specific medical conditions. Endoluminal suturing offers several advantages, such as reduced surgical trauma, shorter recovery times, and less scarring compared to open surgery. At present, endoluminal suturing devices find extensive applications in minimally invasive gastrointestinal surgeries across the globe, revolutionizing the treatment of conditions like obesity and GERD while minimizing patient discomfort and recovery time.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/endoluminal-suturing-devices-market/requestsample
Endoluminal Suturing Devices Market Trends and Drivers:
The global endoluminal suturing devices market is primarily driven by the increasing prevalence of gastrointestinal disorders, obesity, and related conditions and the rising demand for minimally invasive surgical procedures, where endoluminal suturing devices play a critical role in facilitating precise and effective treatments. Apart from this, ongoing advancements in endoscopic and robotic surgical technologies that improve the capabilities and accessibility of endoluminal suturing procedures, expanding their use in various medical specialties, has catalyzed market growth. Besides this, the aging population and the escalating need for less invasive treatment options have fueled market growth as older individuals are more likely to require endoluminal suturing for conditions like gastroesophageal reflux disease (GERD) and obesity. Additionally, the development of novel endoluminal suturing techniques and materials and the increasing surgeon training and expertise that enhance the overall success and adoption of these devices are propelling the market growth. Furthermore, the heightened demand for minimally invasive procedures, including endoluminal suturing amid the coronavirus (COVID-19) pandemic, as patients and healthcare providers prioritize safety and shorter recovery times, is contributing to market growth.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Application:
- Bariatric Surgery
- Gastrointestinal Surgery
- Gastroesophageal Surgery
- Others
Breakup by End Use:
- Hospitals
- Ambulatory Surgical Centers
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Apollo Endosurgery Inc.
- ErgoSuture
- Ovesco Endoscopy AG
- Usgi Medical Inc.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
